MY174494A - Method for inhibiting pathogens using a nutritional composition - Google Patents

Method for inhibiting pathogens using a nutritional composition

Info

Publication number
MY174494A
MY174494A MYPI2013001689A MYPI2013001689A MY174494A MY 174494 A MY174494 A MY 174494A MY PI2013001689 A MYPI2013001689 A MY PI2013001689A MY PI2013001689 A MYPI2013001689 A MY PI2013001689A MY 174494 A MY174494 A MY 174494A
Authority
MY
Malaysia
Prior art keywords
nutritional composition
inhibiting
inhibiting pathogens
human
pathogens
Prior art date
Application number
MYPI2013001689A
Inventor
Anja Wittke
Cecilia Munoz
Dattatreya Banavara
Robert J Mcmahon
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/980,808 external-priority patent/US20120171163A1/en
Priority claimed from US12/980,813 external-priority patent/US8648036B2/en
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of MY174494A publication Critical patent/MY174494A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A method for inhibiting a bacterial invasive or adhesion mechanism involving administering to a human a nutritional composition including a lipid or fat; a protein source; a prebiotic composition; and at least about 10 mg/lOOkCal oflactoferrin produced by a non-human source.
MYPI2013001689A 2010-12-29 2011-12-15 Method for inhibiting pathogens using a nutritional composition MY174494A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/980,808 US20120171163A1 (en) 2010-12-29 2010-12-29 Method for inhibiting a bacterial invasive mechanism using a nutritional composition
US12/980,813 US8648036B2 (en) 2010-12-29 2010-12-29 Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract

Publications (1)

Publication Number Publication Date
MY174494A true MY174494A (en) 2020-04-23

Family

ID=45496273

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2013001689A MY174494A (en) 2010-12-29 2011-12-15 Method for inhibiting pathogens using a nutritional composition

Country Status (13)

Country Link
EP (1) EP2658388A2 (en)
CN (1) CN103327828B (en)
BR (1) BR112013011642B1 (en)
CA (1) CA2822892C (en)
EC (1) ECSP13012798A (en)
MX (1) MX2013006094A (en)
MY (1) MY174494A (en)
PE (1) PE20141192A1 (en)
PH (1) PH12013500916A1 (en)
RU (1) RU2013128920A (en)
SG (2) SG190781A1 (en)
TW (1) TWI626893B (en)
WO (1) WO2012091946A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968722B2 (en) 2010-12-29 2015-03-03 Mead Johnson Nutrition Company Milk-based nutritional compositions containing lactoferrin and uses thereof
RU2015122497A (en) * 2012-12-18 2017-01-26 ЭмДжейЭн Ю.Эс. Холдингс ЛЛК LACTOFERRINE-CONTAINING NUTRITIONAL COMPOSITIONS ON THE BASIS OF MILK AND THEIR APPLICATION
US20140271978A1 (en) * 2013-03-15 2014-09-18 Mead Johnson Nutrition Company Low-buffer nutritional compositions and uses thereof
US9609888B2 (en) * 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US20200276321A1 (en) * 2017-09-10 2020-09-03 Technion Research & Development Foundation Limited Composition and method for a prebiotic delivery system targeted to probiotic bacteria
GB2618609A (en) * 2022-05-13 2023-11-15 Lintbells Ltd Methods and processes for manufacture of a topically adherent selective bactericide
AU2023342478A1 (en) 2022-09-14 2025-03-20 N.V. Nutricia Nutritional composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
ES2157898T3 (en) 1991-01-24 2001-09-01 Martek Corp MICROBIAL OILS AND USES OF THE SAME.
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
ATE209862T1 (en) 1994-02-16 2001-12-15 Pharming Intellectual Pty Bv ISOLATION OF LACTOFERRIN FROM MILK
DK1480524T3 (en) 2002-03-07 2013-07-15 Upfront Chromatography As Method for isolating lactoferrin
CN101247823A (en) * 2005-05-05 2008-08-20 布里斯托尔-迈尔斯斯奎布公司 Application of bovine lactoferrin in preparation of medicine for inhibiting bacterial growth
US20070191264A1 (en) * 2005-05-05 2007-08-16 Bristol-Myers Squibb Company, A Delaware Corporation Methods for inhibiting the growth of bacteria
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
WO2008047391A1 (en) * 2006-10-17 2008-04-24 S.I.F.Fr.A. Farmaceutici Srl Nutriceutic composition comprising lactoferrin and proteasic probiotics
UA103180C2 (en) * 2007-11-26 2013-09-25 Нестек С.А. Infant nutrition system balanced by age
ITRM20080163A1 (en) * 2008-03-26 2009-09-27 Maurizio Acri USE OF LATTOFERRINA FOR THE PREVENTION OF NEONATAL SEPSIS IN PREMATURED NEWBORNS
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
WO2011051482A1 (en) * 2009-10-29 2011-05-05 Nestec S.A. Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof

Also Published As

Publication number Publication date
PH12013500916A1 (en) 2024-06-03
EP2658388A2 (en) 2013-11-06
BR112013011642A2 (en) 2016-07-12
WO2012091946A3 (en) 2012-09-07
ECSP13012798A (en) 2013-09-30
PE20141192A1 (en) 2014-10-01
TW201238503A (en) 2012-10-01
WO2012091946A2 (en) 2012-07-05
BR112013011642B1 (en) 2020-04-07
CN103327828B (en) 2016-05-11
MX2013006094A (en) 2013-07-03
SG10201508194RA (en) 2015-11-27
TWI626893B (en) 2018-06-21
CA2822892A1 (en) 2012-07-05
CN103327828A (en) 2013-09-25
CA2822892C (en) 2020-04-28
HK1189456A1 (en) 2014-06-13
SG190781A1 (en) 2013-07-31
RU2013128920A (en) 2015-02-10

Similar Documents

Publication Publication Date Title
MY174494A (en) Method for inhibiting pathogens using a nutritional composition
PH12012502318A1 (en) Substantially clear nutritional liquids comprising calcium hmb and soluble protein
IN2014DN03449A (en)
MX342733B (en) Nutritional composition to promote healthy development and growth.
MX338245B (en) Methods and compositions for inducing satiety.
MY158504A (en) Fatty acid niacin conjugates and their uses
ZA200805413B (en) Method for modifying gut flora in animals
GB201317630D0 (en) Improvements in or relating to visual performance and/or macular pigmentation in a subject and AMD
BR112013028709A2 (en) bacterial strains capable of metabolizing oxalates
MA33075B1 (en) Formulated to regulate lipid metabolism
GB201101459D0 (en) Novel compounds and thier effects on fedding behaviour
MX2014004722A (en) Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease.
MX2011012297A (en) The improvement of gastrointestinal health, immunity and performance by dietary intervention.
WO2010007332A3 (en) Composition of branched maltodextrins and eukaryotic organisms having a polysaccharide wall, used in the field of well-being
WO2013028555A3 (en) Methods for weight loss and ketogenic compositions
MX343326B (en) Methods for enhancing energy metabolism.
MY161933A (en) Fortified Milk-Based Nutritional Compositions
UA108465C2 (en) Biologically active food supplements
PH12013500917A1 (en) Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
EP2588070B8 (en) USE OF CHICORIC ACID AND LACTIC BACTERIUM IN FOOD SUPPLEMENT FOR lightening and/or whitening skin tone
WO2010119424A3 (en) Composition for regulating the metabolism of lipids
WO2011019875A3 (en) Antioxidant dietary supplement compositions
MX2011011860A (en) Immune stimulating composition comprising an extract of aronia sp. in combination with selenium and/or zinc.
WO2013084052A8 (en) Vitamin b12 producing lactobacillus reuteri strains
IN2012DN06392A (en)